SFS
ADPT icon

Sowell Financial Services’s Adaptive Biotechnologies ADPT Stock Holding History

Sowell Financial Services’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-822
Closed -$30K – 548
2021
Q1 		$30K Buy
822
+477
+138% +$25.8K ﹤0.01% 1861
2020
Q4 		$20K Sell
345
-1,899
-85% -$97.9K ﹤0.01% 1732
2020
Q3 		$109K Sell
2,244
-1,174
-34% -$49.3K 0.01% 945
2020
Q2 		$165K Buy
3,418
+3,073
+891% +$112K 0.01% 790
2020
Q1 		$10K Buy
+345
New +$9.62K ﹤0.01% 1600

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Sowell Financial Services's ADPT Position: Q2 2021 in Review

Sowell Financial Services sold out of Adaptive Biotechnologies (ADPT) in Q2 2021, closing a stake of 822 shares — an estimated $30K sold.

Sowell Financial Services first reported a position in ADPT in Q1 2020 and held it in 5 quarters. The position peaked at $165K in Q2 2020. 231 funds tracked by Wall St. Rank hold ADPT as of Q2 2021.

  • Sowell Financial Services reported no remaining Adaptive Biotechnologies position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 822 Adaptive Biotechnologies shares in Q2 2021, an estimated $30K.
  • Sowell Financial Services first reported a position in Adaptive Biotechnologies in Q1 2020 and held it in 5 quarters.
  • Sowell Financial Services's Adaptive Biotechnologies position peaked at $165K in Q2 2020.
  • 231 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.